Tyra Biosciences (TYRA) Payables (2020 - 2026)

Tyra Biosciences' Payables history runs 7 years deep, the most recent figure standing at $3.6 million for Q1 2026.

• Quarterly Payables rose 45.68% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (up 45.68% YoY) and the FY2025 annual result came in at $1.2 million, up 99.66% from the prior year.
• Payables was $3.6 million for Q1 2026 at Tyra Biosciences, up from $1.2 million in the prior quarter.
• Across five years, Payables topped out at $4.7 million in Q4 2023 and bottomed at $590000.0 in Q4 2024.
• A 5-year average of $2.1 million and a median of $2.0 million in 2025 frame the typical range for Payables.
• Annual changes were most pronounced in 2023 — Payables jumped 307.16% — and 2024, when it sank 87.34%.
• Tyra Biosciences' Payables stood at $1.1 million in 2022, then jumped by 307.16% to $4.7 million in 2023, then sank by 87.34% to $590000.0 in 2024, then soared by 99.66% to $1.2 million in 2025, then surged by 209.17% to $3.6 million in 2026.
• Business Quant data shows TYRA's Payables at $3.6 million in Q1 2026, $1.2 million in Q4 2025, and $2.0 million in Q3 2025.